MedTrace Logo

Effect of Lithium Carbonate in Patients With Amyotrophic Lateral Sclerosis

NCT00925847 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 23

Last updated 2012-10-31

No results posted yet for this study

Summary

The purpose of the study is to determine whether lithium is safe and effective in the treatment of ALS

Conditions

Interventions

DRUG

lithium

lithium LP 400mg daily po (doses were adjusted during the study to maintain targeted blood levels.)

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Lucette Lacomblez, MD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-04-30
Completion
2011-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00925847 on ClinicalTrials.gov